Can You Combine Oral Tranexamic Acid And Prescription Topical Creams?

Can You Combine Oral Tranexamic Acid And Prescription Topical Creams?

As you consider treatment options for your melasma or hyperpigmentation concerns, you may be wondering if combining oral tranexamic acid and prescription topical creams could help you get better results faster. Keep reading to learn if this is a treatment option that could work for you.

How do oral tranexamic acid and prescription topical creams work?

Oral tranexamic acid reduces the production of melanin by inhibiting tyrosinase activity and altering cell interactions. A 12-week study of oral tranexamic acid treatments for melasma showed an average improvement rate of 49% according to the MASI scale (Del Rosario).

Prescription-strength topical creams generally work by interfering with melanin production, typically by reducing melanocytes – cells that produce melanin to protect the skin from UV rays when exposed to the sun.

The “gold standard” topical treatment for melasma is hydroquinone, a lightening agent. It is frequently used in combination with steroids or retinols to prevent skin irritation and increase efficacy. Multiple studies suggest that combination creams including a 4% concentration of hydroquinone, a steroid, and tretinoin (a retinoid) are the most effective (Grimes).

Can you combine oral tranexamic acid with prescription topical creams?

Depending on your skin’s needs, your doctor may recommend a combination of both oral tranexamic acid and prescription topical creams to address your melasma or hyperpigmentation issues.

One study examined a treatment plan of oral tranexamic acid and a 2% hydroquinone triple combination cream. The study found that oral and topical treatments combined led to faster and sustained improvement in melasma patients (Padhi).

Another study found that oral tranexamic acid combined with a 4% hydroquinone cream led to significantly higher patient satisfaction with progress in treating their melasma than topical treatments on their own (Tehranchinia).

Treatment plans typically last 8-12 weeks, though sometimes treatment can last much longer depending on the nature of your skin concerns.

Read more:

Are there any side effects from combining oral tranexamic acid with prescription topical creams?

Tranexamic acid has coagulative properties, which is why it’s also used to treat heavy menstruation. If you have a heart condition or issues with blood clotting, you should be sure to let your doctor know.

Other mild side effects that may occur with oral tranexamic acid include:

  • Mild gastrointestinal discomfort
  • Allergic skin rash
  • Hair loss

Hydroquinone and other topical treatments may cause some mild side effects that should subside once your skin adjusts to treatment, such as:

  • Tenderness or swelling of treatment area
  • UV light sensitivity
  • Skin irritation, including stinging, dry skin, and redness

Treat Hyperpigmentation

Our Dermatologist worked closely with Musely and found The Spot Cream to be the best treatment on the market 👇

References

Brandon Kirsch
brandon.kirsch@clearifirx.com

Brandon Kirsch, MD, FAAD, is a board-certified dermatologist specializing in clinical drug development and medical innovation. He is the founder of Kirsch Dermatology in Naples, Florida and is also the Chief of Dermatology at the Naples Community Hospital. Kirsch Dermatology Website Dr. Kirsch started his career as a lawyer and holds law degrees from the University of Western Ontario (LL.B.) and Georgetown (LL.M. Securities and Financial Regulation). Dr. Kirsch completed his pre-medical studies at the University of Pennsylvania, medical school at Brown University, internship at the Mayo Clinic (Florida) and dermatology residency at the University of North Carolina. In partnership with the Mayo Clinic, he filed to patent a novel topical composition for the treatment of skin hyperpigmentation that he co-developed and also oversaw a successful pilot study of the formulation. Dr. Kirsch has experience with therapeutic drug development programs from pre-clinical to Phase 3 studies. He is licensed to practice medicine in California, Colorado, Florida, and North Carolina and law in New York and Ontario.



Recent Posts